News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
EU Extends Merger Review of Agilent Technologies Inc. (JOBS), Varian, Inc. Deal
December 22, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- EU regulators have extended their review of U.S. electronics company Agilent Technologies Inc's (A.N) plan to buy Varian Inc (VARI.O) after Agilent offered remedies to tackle competition concerns.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Agilent Technologies
MORE ON THIS TOPIC
Manufacturing
Roche licensing pact clears generic drugmakers to manufacture antiviral flu drug
May 21, 2026
·
2 min read
·
Nick Paul Taylor
Artificial intelligence
Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling
May 21, 2026
·
3 min read
·
Tristan Manalac
Deals
Lilly and Engage Bio tie the knot with $202M acquisition
May 20, 2026
·
2 min read
·
Gabrielle Masson
Deals
Regeneron, Parabilis set out to create new drug class in deal worth up to $2.3B
May 18, 2026
·
2 min read
·
Gabrielle Masson